Allergic Rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Two or more symptoms, such as paroxysmal sneezing, watery nose, nasal itching and nasal congestion, persist or accumulate for more than 1 hour per day (quality of life (including sleep, daily life, work and study have no significant impact); 2.The signs were pale and swollen nasal mucosa, edema of inferior turbinate and watery secretion of nasal cavity; 3.Age 18-85 years old; 4. Voluntarily participate in this study and be able to cooperate with the follow-up work of this study, and be able to understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Does not meet the above inclusion criteria; 2. A known history of allergy to the investigational agent or any of its related ingredients; 3. Participate in other clinical trials within the past 1 month; 4. Patients with sinusitis, drug-induced rhinitis, and nasal polyps; 5. Serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total nasal symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life scores;total non-nasal symptom score; | — |
Countries
China
Contacts
Chinese PLA General Hospital